ARRY-382

Ligand id: 9108

Name: ARRY-382

References
1. Bendell J et al.
A Phase 1 Study of ARRY-382, an Oral Inhibitor of Colony-stimulating Factor-1 Receptor (CSF1R), in Patients with Advanced or Metastatic Cancers.
Accessed on 14/04/2016. Modified on 14/04/2016. Arraybiopharma.com, http://www.arraybiopharma.com/files/3014/4501/8593/382-101_AACR-NCI-EORTC_poster.pdf